Double maintains 12 strategies that include VRTX - Vertex Pharmaceuticals, Inc.
Current Value
$424.691 Year Return
Current Value
$424.691 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KRYS | 46.46% | $3.80B | -19.49% | 0.00% |
REGN | 43.40% | $61.69B | -41.59% | 0.00% |
AMGN | 41.71% | $141.03B | -17.79% | 3.45% |
PFE | 39.57% | $125.19B | -23.59% | 7.64% |
ABBV | 39.21% | $313.43B | +8.33% | 3.58% |
TECH | 38.64% | $7.50B | -42.68% | 0.50% |
SNDX | 38.38% | $798.52M | -57.70% | 0.00% |
RGNX | 37.98% | $417.84M | -48.68% | 0.00% |
IDYA | 37.06% | $1.50B | -59.71% | 0.00% |
CSGP | 36.75% | $31.93B | -14.46% | 0.00% |
AVB | 36.72% | $28.70B | +1.58% | 3.39% |
ROIV | 36.72% | $7.61B | -7.22% | 0.00% |
AVY | 36.00% | $14.11B | -20.17% | 1.95% |
BIIB | 35.95% | $17.64B | -48.85% | 0.00% |
ACLX | 35.94% | $3.25B | +14.11% | 0.00% |
HSTM | 35.61% | $826.63M | -0.66% | 0.32% |
MFA | 35.37% | $982.39M | -12.84% | 14.67% |
RCKT | 35.23% | $652.35M | -74.41% | 0.00% |
NVS | 34.99% | $199.23B | +1.71% | 3.73% |
ESS | 34.59% | $17.94B | +4.03% | 3.55% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
URNM | 0.04% | $1.43B | 0.75% |
PDBC | -0.07% | $4.36B | 0.59% |
GSG | -0.43% | $904.64M | 0.75% |
DBC | 0.45% | $1.16B | 0.87% |
UGA | 0.47% | $72.35M | 0.97% |
BSCP | 0.51% | $3.50B | 0.1% |
XBIL | -0.52% | $782.35M | 0.15% |
SPTS | 0.57% | $5.76B | 0.03% |
KBA | -0.60% | $175.04M | 0.56% |
BOXX | 0.62% | $6.18B | 0.19% |
XONE | 0.62% | $601.30M | 0.03% |
BILZ | -0.79% | $880.81M | 0.14% |
GLDM | 0.88% | $14.45B | 0.1% |
TFLO | 0.89% | $7.09B | 0.15% |
COMT | -0.96% | $597.41M | 0.48% |
BAR | 0.98% | $1.11B | 0.1749% |
SGOL | 1.18% | $5.07B | 0.17% |
IBDQ | -1.21% | $3.08B | 0.1% |
GLD | 1.32% | $97.40B | 0.4% |
IAU | 1.36% | $45.71B | 0.25% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AIFU | -18.18% | $9.78M | -95.05% | 0.00% |
MQ | -13.83% | $2.29B | -16.38% | 0.00% |
CPSH | -11.79% | $26.00M | +4.68% | 0.00% |
CNK | -11.01% | $3.58B | +66.36% | 0.26% |
LMB | -10.86% | $1.43B | +142.44% | 0.00% |
DHC | -9.45% | $716.52M | +24.79% | 1.36% |
AORT | -9.43% | $1.24B | +22.12% | 0.00% |
STG | -9.01% | $26.71M | -39.86% | 0.00% |
MNOV | -8.90% | $67.19M | -8.05% | 0.00% |
MESO | -8.79% | $1.47B | +60.28% | 0.00% |
QNRX | -8.15% | $4.50M | -71.83% | 0.00% |
FATBB | -7.52% | $50.08M | -14.21% | 14.95% |
EVGO | -7.51% | $543.38M | +71.61% | 0.00% |
TIMB | -7.28% | $8.60B | +7.96% | 2.93% |
FARO | -7.27% | $812.69M | +120.04% | 0.00% |
SEG | -6.18% | $244.37M | -25.25% | 0.00% |
USM | -5.79% | $5.13B | +35.50% | 0.00% |
BTCT | -5.78% | $26.25M | +84.62% | 0.00% |
ACI | -5.54% | $12.40B | +3.51% | 2.51% |
OKLO | -5.41% | $5.15B | +260.37% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -33.37% | $102.66M | 0.85% |
TAIL | -19.47% | $145.16M | 0.59% |
BTAL | -14.88% | $367.96M | 1.43% |
CLIP | -12.97% | $1.51B | 0.07% |
TPMN | -9.13% | $31.21M | 0.65% |
IVOL | -8.88% | $351.97M | 1.02% |
BILS | -5.49% | $3.97B | 0.1356% |
KCCA | -5.10% | $97.87M | 0.87% |
UNG | -4.91% | $371.70M | 1.06% |
ULST | -4.90% | $637.67M | 0.2% |
GBIL | -4.85% | $6.17B | 0.12% |
BNO | -4.59% | $83.96M | 1% |
USO | -4.58% | $957.61M | 0.6% |
XHLF | -4.53% | $1.46B | 0.03% |
OILK | -4.34% | $61.84M | 0.69% |
USL | -4.23% | $40.86M | 0.85% |
TBLL | -4.04% | $2.46B | 0.08% |
CTA | -3.59% | $1.03B | 0.76% |
DBE | -3.41% | $47.45M | 0.77% |
KRBN | -3.27% | $160.46M | 0.85% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BBH | 60.40% | $333.72M | 0.35% |
IBB | 57.27% | $5.37B | 0.45% |
VHT | 50.48% | $15.34B | 0.09% |
FBT | 50.31% | $1.02B | 0.56% |
FHLC | 49.79% | $2.49B | 0.084% |
IXJ | 49.71% | $3.87B | 0.41% |
XLV | 49.69% | $35.70B | 0.09% |
IYH | 49.52% | $2.85B | 0.39% |
XBI | 48.26% | $5.05B | 0.35% |
PBE | 46.23% | $219.87M | 0.58% |
PPH | 44.77% | $621.67M | 0.36% |
RSPH | 43.62% | $769.59M | 0.4% |
PINK | 42.90% | $134.87M | 0.5% |
IHE | 42.22% | $562.13M | 0.39% |
FXH | 42.00% | $903.50M | 0.62% |
GNOM | 40.94% | $41.32M | 0.5% |
XPH | 38.64% | $139.13M | 0.35% |
USMV | 38.36% | $24.02B | 0.15% |
FDLO | 38.05% | $1.19B | 0.16% |
ACWV | 36.81% | $3.41B | 0.2% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
HMST | -0.03% | $239.92M | +24.93% | 0.00% |
FRPT | -0.03% | $3.84B | -38.80% | 0.00% |
TEF | 0.04% | $26.92B | +6.24% | 6.63% |
POWL | 0.09% | $2.23B | +10.46% | 0.58% |
ARMK | -0.09% | $10.22B | +15.94% | 1.05% |
GDOT | -0.09% | $554.40M | -0.49% | 0.00% |
ULS | 0.10% | $14.01B | +87.95% | 0.72% |
QXO | 0.12% | $8.32B | -84.77% | 0.00% |
SHLS | 0.13% | $1.02B | -10.01% | 0.00% |
SATS | 0.15% | $6.53B | +30.57% | 0.00% |
OMAB | 0.19% | $4.21B | +14.57% | 4.73% |
SOC | 0.24% | $2.55B | +131.04% | 0.00% |
VST | -0.25% | $52.50B | +59.65% | 0.58% |
ATEC | 0.27% | $1.86B | +11.07% | 0.00% |
PRPL | -0.31% | $89.27M | -44.26% | 0.00% |
LITB | -0.40% | $22.99M | -70.67% | 0.00% |
TME | 0.40% | $11.89B | +10.61% | 1.91% |
HDSN | -0.41% | $330.02M | -17.68% | 0.00% |
ALTO | 0.46% | $69.48M | -49.44% | 0.00% |
SMCI | 0.48% | $26.86B | -52.75% | 0.00% |
MarketWatch
Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Finnhub
Vertex Pharmaceuticals Incorporated today announced management participation in three upcoming investor conferences.Susie Lisa, Senior Vice President, Investor Relations, and Manisha Pai,...
MarketWatch
Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day
Yahoo
CRISPR Therapeutics has an approved gene-therapy treatment still in its early growth stages. One of them is CRISPR Therapeutics (NASDAQ: CRSP). Its financials haven't been looking all that impressive and as a result, growth investors have been dumping the stock.
MarketWatch
Verve Therapeutics Shares Rise After Narrower-Than-Expected 1Q Loss
SeekingAlpha
The VanEck Biotech ETF offers lower risk with established companies, but 23% of AUM in speculative stocks poses a risk. Check out why I rate BBH a sell.